Vectura Demands Another $44M In Inhaler IP Clash
British pharma company Vectura has asked a Delaware federal judge to pile another nearly $44 million onto the damages GlaxoSmithKline owes after a jury found GSK willfully infringed a patent covering...To view the full article, register now.
Already a subscriber? Click here to view full article